Zepbound is available in both prefilled pens and vials, with the pens offering a wider range of doses and the vials requiring syringe administration. If deemed appropriate, the healthcare ...

Doctors argue that both drugs should remain available because some patients in fact do better on Wegovy than on Zepbound, losing more weight or experiencing fewer or milder side effects.

Eli Lilly’s Zepbound proved more effective than Novo Nordisk’s Wegovy in a new head-to-head trial, though both medications ...

CVS’s drug-benefits unit, known as Caremark, earlier this month negotiated a deal to make Novo’s Wegovy more widely available to its customers — knocking Eli Lilly & Co.’s Zepbound off its ...

Share on Pinterest Tirzepatide (Zepbound) led to more weight loss than ... As more options become available, patients and providers can better tailor treatment to individual needs and preferences.

When the Food and Drug Administration (FDA) approved Byetta (exenatide) in 2005, doctors thought it was just approving the ...

The 2.5mg vial is available at $399 per month. Lilly claims the single-dose versions cost at least 50% less than the list price of other incretin medicines for obesity. "Offering Zepbound single ...

Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...

American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...

The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...